Pluripotent Stem Cells As a Robust Source of Mesenchymal Stem Cells

Overview

Journal Stem Cell Rev Rep

Publisher Springer

Specialty Cell Biology

Date 2016 Nov 6

PMID 27815690

Citations 36

Authors

Carlos D Luzzani

Santiago G Miriuka

Affiliations

Soon will be listed here.

Abstract

Mesenchymal stem cells (MSC) have been extensively studied over the past years for the treatment of different diseases. Most of the ongoing clinical trials currently involve the use of MSC derived from adult tissues. This source may have some limitations, particularly with therapies that may require extensive and repetitive cell dosage. However, nowadays, there is a staggering growth in literature on a new source of MSC. There is now increasing evidence about the mesenchymal differentiation from pluripotent stem cell (PSC). Here, we summarize the current knowledge of pluripotent-derived mesenchymal stem cells (PD-MSC). We present a historical perspective on the subject, and then discuss some critical questions that remain unanswered.

Citing Articles

Stem cell-derived extracellular vesicles in the therapeutic intervention of Alzheimer's Disease, Parkinson's Disease, and stroke.

Zhou W, Wang X, Dong Y, Gao P, Zhao X, Wang M Theranostics. 2024; 14(8):3358-3384.

PMID: 38855176 PMC: 11155406. DOI: 10.7150/thno.95953.

Lineage-Specific Mesenchymal Stromal Cells Derived from Human iPSCs Showed Distinct Patterns in Transcriptomic Profile and Extracellular Vesicle Production.

Winston T, Song Y, Shi H, Yang J, Alsudais M, Kontaridis M Adv Sci (Weinh). 2024; 11(28):e2308975.

PMID: 38757640 PMC: 11267277. DOI: 10.1002/advs.202308975.

Unveiling heterogeneity in MSCs: exploring marker-based strategies for defining MSC subpopulations.

Chen S, Liang B, Xu J J Transl Med. 2024; 22(1):459.

PMID: 38750573 PMC: 11094970. DOI: 10.1186/s12967-024-05294-5.

Therapeutic potential of mesenchymal stem cells from human iPSC-derived teratomas for osteochondral defect regeneration.

Kim J, Kim J, Kim D, Bello A, Kim B, Cha B Bioeng Transl Med. 2024; 9(2):e10629.

PMID: 38435815 PMC: 10905541. DOI: 10.1002/btm2.10629.

Potential and Limitations of Induced Pluripotent Stem Cells-Derived Mesenchymal Stem Cells in Musculoskeletal Disorders Treatment.

Dias I, Cordeiro A, Matheus Guimaraes J, Silva K Biomolecules. 2023; 13(9).

PMID: 37759742 PMC: 10526864. DOI: 10.3390/biom13091342.

References

Mohyeddin Bonab M, Alimoghaddam K, Talebian F, Ghaffari S, Ghavamzadeh A, Nikbin B . Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006; 7:14. PMC: 1435883. DOI: 10.1186/1471-2121-7-14. View

Hwang N, Varghese S, Lee H, Zhang Z, Ye Z, Bae J . In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A. 2008; 105(52):20641-6. PMC: 2634917. DOI: 10.1073/pnas.0809680106. View

Diederichs S, Tuan R . Functional comparison of human-induced pluripotent stem cell-derived mesenchymal cells and bone marrow-derived mesenchymal stromal cells from the same donor. Stem Cells Dev. 2014; 23(14):1594-610. PMC: 4086513. DOI: 10.1089/scd.2013.0477. View

Qi X, Zhang J, Yuan H, Xu Z, Li Q, Niu X . Exosomes Secreted by Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Repair Critical-Sized Bone Defects through Enhanced Angiogenesis and Osteogenesis in Osteoporotic Rats. Int J Biol Sci. 2016; 12(7):836-49. PMC: 4910602. DOI: 10.7150/ijbs.14809. View

Barberi T, Willis L, Socci N, Studer L . Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med. 2005; 2(6):e161. PMC: 1160574. DOI: 10.1371/journal.pmed.0020161. View

Luzzani C, Neiman G, Garate X, Questa M, Solari C, Fernandez Espinosa D . A therapy-grade protocol for differentiation of pluripotent stem cells into mesenchymal stem cells using platelet lysate as supplement. Stem Cell Res Ther. 2015; 6:6. PMC: 4417240. DOI: 10.1186/scrt540. View

Haniffa M, Collin M, Buckley C, Dazzi F . Mesenchymal stem cells: the fibroblasts' new clothes?. Haematologica. 2008; 94(2):258-63. PMC: 2635401. DOI: 10.3324/haematol.13699. View

Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O . HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003; 31(10):890-6. DOI: 10.1016/s0301-472x(03)00110-3. View

Kang R, Zhou Y, Tan S, Zhou G, Aagaard L, Xie L . Mesenchymal stem cells derived from human induced pluripotent stem cells retain adequate osteogenicity and chondrogenicity but less adipogenicity. Stem Cell Res Ther. 2015; 6:144. PMC: 4539932. DOI: 10.1186/s13287-015-0137-7. View

10.

Hajizadeh-Saffar E, Tahamtani Y, Aghdami N, Azadmanesh K, Habibi-Anbouhi M, Heremans Y . Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes. Sci Rep. 2015; 5:9322. PMC: 4377549. DOI: 10.1038/srep09322. View

11.

Fu X, Chen Y, Xie F, Dong P, Liu W, Cao Y . Comparison of immunological characteristics of mesenchymal stem cells derived from human embryonic stem cells and bone marrow. Tissue Eng Part A. 2014; 21(3-4):616-26. PMC: 4334098. DOI: 10.1089/ten.TEA.2013.0651. View

12.

Zhang Y, Liao S, Yang M, Liang X, Poon M, Wong C . Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension. Cell Transplant. 2012; 21(10):2225-39. DOI: 10.3727/096368912X653020. View

13.

Ullmann U, Int Veld P, Gilles C, Sermon K, De Rycke M, van de Velde H . Epithelial-mesenchymal transition process in human embryonic stem cells cultured in feeder-free conditions. Mol Hum Reprod. 2006; 13(1):21-32. DOI: 10.1093/molehr/gal091. View

14.

Li O, Tormin A, Sundberg B, Hyllner J, Le Blanc K, Scheding S . Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies. PLoS One. 2013; 8(1):e55319. PMC: 3558469. DOI: 10.1371/journal.pone.0055319. View

15.

de Peppo G, Marolt D . Modulating the biochemical and biophysical culture environment to enhance osteogenic differentiation and maturation of human pluripotent stem cell-derived mesenchymal progenitors. Stem Cell Res Ther. 2013; 4(5):106. PMC: 3854688. DOI: 10.1186/scrt317. View

16.

Du J, Wu Y, Ai Z, Shi X, Chen L, Guo Z . Mechanism of SB431542 in inhibiting mouse embryonic stem cell differentiation. Cell Signal. 2014; 26(10):2107-16. DOI: 10.1016/j.cellsig.2014.06.002. View

17.

Frobel J, Hemeda H, Lenz M, Abagnale G, Joussen S, Denecke B . Epigenetic rejuvenation of mesenchymal stromal cells derived from induced pluripotent stem cells. Stem Cell Reports. 2014; 3(3):414-22. PMC: 4266008. DOI: 10.1016/j.stemcr.2014.07.003. View

18.

Baxter M, Wynn R, Jowitt S, Wraith J, Fairbairn L, Bellantuono I . Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells. 2004; 22(5):675-82. DOI: 10.1634/stemcells.22-5-675. View

19.

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

20.

Sun Y, Zhang Y, Li X, Deng M, Gao W, Yao Y . Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice. Stem Cells. 2015; 33(12):3452-67. DOI: 10.1002/stem.2094. View